HUT62799A - Process for producing pharmaceutical composition comprising xanthine derivative and improving blood permeability of brain - Google Patents

Process for producing pharmaceutical composition comprising xanthine derivative and improving blood permeability of brain Download PDF

Info

Publication number
HUT62799A
HUT62799A HU9203909A HU9203909A HUT62799A HU T62799 A HUT62799 A HU T62799A HU 9203909 A HU9203909 A HU 9203909A HU 9203909 A HU9203909 A HU 9203909A HU T62799 A HUT62799 A HU T62799A
Authority
HU
Hungary
Prior art keywords
alkyl
straight
branched
oxoalkyl
formula
Prior art date
Application number
HU9203909A
Other languages
English (en)
Hungarian (hu)
Inventor
Rolf Kolvenbach
John Grome
Ernst-Juergen Schneider
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HUT62799A publication Critical patent/HUT62799A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9203909A 1991-12-11 1992-12-10 Process for producing pharmaceutical composition comprising xanthine derivative and improving blood permeability of brain HUT62799A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140805 1991-12-11

Publications (1)

Publication Number Publication Date
HUT62799A true HUT62799A (en) 1993-06-28

Family

ID=6446782

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9203909A HUT62799A (en) 1991-12-11 1992-12-10 Process for producing pharmaceutical composition comprising xanthine derivative and improving blood permeability of brain
HU9203909A HU9203909D0 (en) 1991-12-11 1992-12-10 Method for producing medical preparatives of xanthene content improving blood throughflow in brain

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9203909A HU9203909D0 (en) 1991-12-11 1992-12-10 Method for producing medical preparatives of xanthene content improving blood throughflow in brain

Country Status (10)

Country Link
EP (1) EP0547508A1 (enExample)
JP (1) JPH05246850A (enExample)
KR (1) KR930012020A (enExample)
AU (1) AU3000292A (enExample)
CA (1) CA2085046A1 (enExample)
HU (2) HUT62799A (enExample)
IL (1) IL104037A0 (enExample)
MX (1) MX9207156A (enExample)
TW (1) TW209834B (enExample)
ZA (1) ZA929566B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
WO2025046257A1 (en) * 2023-08-25 2025-03-06 Hikal Limited A substantially pure propentofylline and preparation thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
DE3942871A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel

Also Published As

Publication number Publication date
MX9207156A (es) 1993-06-01
AU3000292A (en) 1993-06-17
IL104037A0 (en) 1993-05-13
JPH05246850A (ja) 1993-09-24
TW209834B (enExample) 1993-07-21
EP0547508A1 (de) 1993-06-23
KR930012020A (ko) 1993-07-20
ZA929566B (en) 1993-06-16
HU9203909D0 (en) 1993-03-29
CA2085046A1 (en) 1993-06-12

Similar Documents

Publication Publication Date Title
EP0220696A2 (en) Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety
JPH02121935A (ja) 大脳卒中の治療のための薬剤
JPH0531523B2 (enExample)
FI120403B (fi) 4-(2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena
JP3436547B2 (ja) 頭蓋脳外傷後の二次的神経細胞損傷および機能疾患を治療するためのキサンチン誘導体の使用
JP3408546B2 (ja) 抗喘息剤
HUT62799A (en) Process for producing pharmaceutical composition comprising xanthine derivative and improving blood permeability of brain
CN102134242B (zh) 一种用于治疗阳痿的快速长效的化合物
JP2003201255A (ja) アルツハイマー病予防および治療剤
EP1437137B1 (en) Drugs comprising combination of antithrombotic agent with pyrazolone derivative
WO2006035617A1 (ja) インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
JPH0820531A (ja) 緑内障治療剤及び眼圧降下剤
HU181944B (en) Process for preparing /+/-/3alpha,16alpha/-14-imino-/15h/-eburnamenine
CA2157671A1 (en) Medicament for treating or preventing cerebrovascular diseases
AU651205B2 (en) The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
JPH0741424A (ja) 抗炎症剤
EP0413751A1 (en) Neurologically active compounds
EP0759298B1 (en) Use of 4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine for the manufacture of an antihypertensive agent
EP0042162A2 (en) Compositions for treating diseases in circulatory organs
EP0301239B1 (en) Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
JP2003267871A (ja) 放射線障害予防剤
EP0115331B1 (en) Medicament for cerebral apoplexy
JP3388775B2 (ja) 脳障害改善剤
CN117462556A (zh) 咔唑衍生物y16在制备治疗心血管疾病药物中的应用
JP4582561B2 (ja) 移植による血管病変の発生抑制剤

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal